Thorac Cardiovasc Surg 2019; 67(S 01): S1-S100
DOI: 10.1055/s-0039-1678987
Short Presentations
Monday, February 18, 2019
DGTHG: Auf den Punkt gebracht - Grundlagenforschung
Georg Thieme Verlag KG Stuttgart · New York

A Monocyte Inspired Guiding System: Targeting of Exosomes to Ischemia Activated Microvascular Endothelium

M.-T. Nazari-Shafti
1   German Heart Center Berlin, Berlin, Germany
2   Deutsches Zentrum für Herz- und Kreislauf-Forschung, Berlin, Germany
,
A. Duran Garcia
3   Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
,
K. Klose
3   Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
,
K. Van Praet
1   German Heart Center Berlin, Berlin, Germany
,
A. J. Maring
3   Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
,
V. Falk
1   German Heart Center Berlin, Berlin, Germany
,
C. Stamm
1   German Heart Center Berlin, Berlin, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
28 January 2019 (online)

Objectives: Exosomes derived from mesenchymal stem cells (MSCs) contain immunomodulatory and angiogenic factors that decrease remodeling after myocardial infarction. In clinical settings, repetitive delivery of exosomes is necessary due to the short half-life of exosomes. Multiple intravenous injections of exosomes in the early stages after MI are easy and minimally invasive. However, past studies have shown that intravenously injected exosomes accumulate in lung and liver.

We hypothesize that overexpression of monocyte adhesion molecules on MSC derived exosomes enables targeted delivery of exosome content to ischemia activated microvascular endothelium.

Methods: In this study, we aim to transiently overexpress E- and P-selectin specific ligands PSGL-1 and SLeX with modified mRNA (mmRNA) in adipose tissue derived MSCs (AT-MSCs). Additionally, luciferase is transiently expressed with mmRNA for in vivo tracking of exosomes. We hypothesize that exosomes isolated from these MSCs will express PSGL-1 and SLeX and will target ischemia induced microvascular endothelium in vitro and in vivo.

Results: As the first step for this project we aimed to create MSC derived exosomes that contain an in vivo tracking protein like luciferase. We successfully isolated exosomes from human AT-MSCs using a commercially available precipitation assay. Western blot analysis showed expression of CD63 and flotillin-1. Dynamic light scatter analysis demonstrated that isolated exosomes were within the expected size range of 131 ± 1.5 nm. After transient expression of luciferase we were able to demonstrate that exosomes exhibited 1.09 × 107 ± 3.4 × 105 RLU/µg protein of luciferase activity which compared to a luciferase activity of the primary cell lysate.

Conclusions: Targeted exosomes can be a powerful therapeutic platform to deliver various immunomodulatory and angiogenic miRNAs to limit post-ischemic remodeling. We have demonstrated that transient expression of proteins such as luciferase in MSCs results in expression of the same proteins in the exosome fraction of transfected cells.